journal article·2017-08-18Open access

An update on applications of nanostructured drug delivery systems in cancer therapy: a review

Seyed Mohsen Aberoumandi, Majid Mohammadhosseini, Elham Abasi, Sepideh Saghati, Nasrin Nikzamir, Abolfazl Akbarzadeh, Yunes Panahi, Soodabeh Davaran

Abstract

Cancer is a main public health problem that is known as a malignant tumor and out-of-control cell growth, with the potential to assault or spread to other parts of the body. Recently, remarkable efforts have been devoted to develop nanotechnology to improve the delivery of anticancer drug to tumor tissue as minimizing its distribution and toxicity in healthy tissue. Nanotechnology has been extensively used in the advance of new strategies for drug delivery and cancer therapy. Compared to customary drug delivery systems, nano-based drug delivery method has greater potential in different areas, like multiple targeting functionalization, in vivo imaging, extended circulation time, systemic control release, and combined drug delivery. Nanofibers are used for different medical applications such as drug delivery systems.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Electrospun Nanofibers in Biomedical Applications · Nanoparticle-Based Drug Delivery · Graphene and Nanomaterials Applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Clinical Sciences, Tabriz Branch, Islamic Azad University, Tabriz, Iran;

Young Researchers and Elite Club, Tabriz Branch, Islamic Azad University, Tabriz, Iran;

Chemical Injuries Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran;

Department of Chemistry, Shahrood Branch, Islamic Azad University, Shahrood, Iran;

Drug Applied Research Center, Tabriz University of Medical Sciences, Tabriz, Iran;

Student Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran

Universal Scientific Education and Research Network (USERN), Tabriz, Iran;

Department of Basic Sciences, Science and Research Branch, Islamic Azad University, Tehran, Iran;

Biotechnology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran;

References (100+)

Show source-provided references
1. 10.1186/1556-276X-9-24710.1186/1556-276X-9-247 ↗
2. 10.3109/1040841X.2014.91220010.3109/1040841X.2014.912200 ↗
3. 10.1593/neo.1161210.1593/neo.11612 ↗
4. 10.1007/s11033-013-3014-410.1007/s11033-013-3014-4 ↗
5. Al Faraj A · Int J Nanomed · 2015 · 10 · 157
6. 10.7314/APJCP.2014.15.1.4910.7314/APJCP.2014.15.1.49 ↗
7. Alizadeh E · Chem Biol Drug Des · 2014 · 85 · 600
8. 10.1111/cbdd.1266410.1111/cbdd.12664 ↗
9. 10.3109/21691401.2014.92877810.3109/21691401.2014.928778 ↗
10. 10.1126/science.109583310.1126/science.1095833 ↗
11. 10.1016/j.biomaterials.2011.07.00510.1016/j.biomaterials.2011.07.005 ↗
12. 10.1007/s10529-006-9145-010.1007/s10529-006-9145-0 ↗
13. 10.1073/pnas.121454711010.1073/pnas.1214547110 ↗
14. 10.1038/nature0523610.1038/nature05236 ↗
15. 10.1007/s11095-008-9710-410.1007/s11095-008-9710-4 ↗
16. 10.1016/j.ejps.2012.01.00910.1016/j.ejps.2012.01.009 ↗
17. 10.1016/j.biocel.2004.01.01310.1016/j.biocel.2004.01.013 ↗
18. 10.1016/j.antiviral.2013.09.02210.1016/j.antiviral.2013.09.022 ↗
19. 10.1016/j.addr.2009.07.01310.1016/j.addr.2009.07.013 ↗
20. 10.1016/j.ijpharm.2012.02.01010.1016/j.ijpharm.2012.02.010 ↗
21. 10.1517/17425247.2011.61079010.1517/17425247.2011.610790 ↗
22. 10.1016/j.jconrel.2012.11.00510.1016/j.jconrel.2012.11.005 ↗
23. 10.1166/jbns.2013.117710.1166/jbns.2013.1177 ↗
24. 10.1016/j.biomaterials.2007.10.02510.1016/j.biomaterials.2007.10.025 ↗
25. 10.1016/j.biomaterials.2008.10.00410.1016/j.biomaterials.2008.10.004 ↗
26. 10.1016/j.biomaterials.2013.06.04110.1016/j.biomaterials.2013.06.041 ↗
27. 10.1002/glia.2088410.1002/glia.20884 ↗
28. 10.1016/j.actbio.2008.02.02010.1016/j.actbio.2008.02.020 ↗
29. 10.1007/s11095-006-0284-810.1007/s11095-006-0284-8 ↗
30. 10.1089/ten.teb.2011.023810.1089/ten.teb.2011.0238 ↗
31. 10.3109/21691401.2014.95363310.3109/21691401.2014.953633 ↗
32. 10.1111/j.1365-2184.2008.00515.x10.1111/j.1365-2184.2008.00515.x ↗
33. 10.7314/APJCP.2014.15.10.435310.7314/APJCP.2014.15.10.4353 ↗
34. 10.3390/ph611136110.3390/ph6111361 ↗
35. 10.1186/1556-276X-9-39310.1186/1556-276X-9-393 ↗
36. 10.3109/21691401.2014.92256810.3109/21691401.2014.922568 ↗
37. Ebrahimnezhad Z · BioImpacts · 2013 · 3 · 67
38. Elham A · Artif Cells Nanomed Biotechnol · 2014 · 1
39. Eommolbanin E · Artif Cells Nanomed Biotechnol · 2014 · 1
40. 10.1021/nn900002m10.1021/nn900002m ↗
41. 10.3109/21691401.2014.93445610.3109/21691401.2014.934456 ↗
42. 10.1038/nrc156610.1038/nrc1566 ↗
43. 10.1021/ar900035f10.1021/ar900035f ↗
44. 10.1038/srep0253410.1038/srep02534 ↗
45. 10.2217/17435889.4.1.1110.2217/17435889.4.1.11 ↗
46. 10.7314/APJCP.2013.14.11.694910.7314/APJCP.2013.14.11.6949 ↗
47. 10.1227/00006123-199508000-0001510.1227/00006123-199508000-00015 ↗
48. 10.1166/jbn.2014.188510.1166/jbn.2014.1885 ↗
49. 10.3109/21691401.2014.95510710.3109/21691401.2014.955107 ↗
50. 10.1016/S0168-3659(02)00008-110.1016/S0168-3659(02)00008-1 ↗
51. He W · Res J Appl Sci Eng Technol · 2014 · 7 · 302210.19026/rjaset.7.637 ↗
52. 10.1016/j.jconrel.2006.10.00710.1016/j.jconrel.2006.10.007 ↗
53. 10.1111/cbdd.1231810.1111/cbdd.12318 ↗
54. 10.1118/1.480509710.1118/1.4805097 ↗
55. 10.1016/S0266-3538(03)00178-710.1016/S0266-3538(03)00178-7 ↗
56. Jemal A · Onkol Dypl · 2006 · 3 · 6
57. 10.3109/21691401.2014.94464410.3109/21691401.2014.944644 ↗
58. 10.1089/ten.tec.2008.048610.1089/ten.tec.2008.0486 ↗
59. 10.1166/jnn.2014.908310.1166/jnn.2014.9083 ↗
60. Jovanov-Milosevic N · Coll Antropol · 2006 · 30 · 375
61. 10.1016/j.biomaterials.2010.11.00610.1016/j.biomaterials.2010.11.006 ↗
62. 10.1016/0168-3659(93)90172-210.1016/0168-3659(93)90172-2 ↗
63. 10.5483/BMBRep.2006.39.4.33910.5483/BMBRep.2006.39.4.339 ↗
64. 10.1002/adfm.20130074610.1002/adfm.201300746 ↗
65. 10.1186/1556-276X-9-13110.1186/1556-276X-9-131 ↗
66. 10.1016/j.ijpharm.2013.07.01910.1016/j.ijpharm.2013.07.019 ↗
67. 10.1371/journal.pone.005752210.1371/journal.pone.0057522 ↗
68. Langer R. · Nature · 1998 · 392 · 5
69. 10.1016/j.biomaterials.2013.06.01010.1016/j.biomaterials.2013.06.010 ↗
70. 10.1016/j.ejpb.2006.11.00910.1016/j.ejpb.2006.11.009 ↗
71. 10.1016/j.cej.2012.10.08910.1016/j.cej.2012.10.089 ↗
72. 10.1016/j.biotechadv.2013.11.00910.1016/j.biotechadv.2013.11.009 ↗
73. 10.1039/C2TB00121G10.1039/C2TB00121G ↗
74. 10.2147/IJN.S7509810.2147/IJN.S75098 ↗
75. 10.1146/annurev.pathol.1.110304.10004310.1146/annurev.pathol.1.110304.100043 ↗
76. 10.1016/j.cbpa.2009.03.02210.1016/j.cbpa.2009.03.022 ↗
77. 10.1166/jbn.2015.190710.1166/jbn.2015.1907 ↗
78. 10.1002/(SICI)1097-4636(199907)46:1<60::AID-JBM7>3.0.CO;2-H10.1002/(SICI)1097-4636(199907)46:1<60::AID-JBM7>3.0.CO;2-H ↗
79. 10.1002/jps.2357710.1002/jps.23577 ↗
80. 10.4103/0250-474X.5601510.4103/0250-474X.56015 ↗
81. 10.1016/j.antiviral.2010.09.00310.1016/j.antiviral.2010.09.003 ↗
82. Matsumura Y · Cancer Res · 1986 · 46 · 6387
83. 10.1038/nrc189310.1038/nrc1893 ↗
84. Mohammad P-M · IET Digital Library · 2014 · 4 · 5
85. 10.7314/APJCP.2013.14.11.692510.7314/APJCP.2013.14.11.6925 ↗
86. 10.1016/j.ijpharm.2009.10.01810.1016/j.ijpharm.2009.10.018 ↗
87. 10.1016/S1535-6108(03)00276-910.1016/S1535-6108(03)00276-9 ↗
88. 10.7150/thno.869810.7150/thno.8698 ↗
89. 10.1021/nl503654t10.1021/nl503654t ↗
90. 10.3109/21691401.2014.95363210.3109/21691401.2014.953632 ↗
91. 10.7314/APJCP.2013.14.11.659510.7314/APJCP.2013.14.11.6595 ↗
92. 10.1007/s12274-012-0202-910.1007/s12274-012-0202-9 ↗
93. 10.1021/ja210557510.1021/ja2105575 ↗
94. 10.1039/C2CS35265F10.1039/C2CS35265F ↗
95. 10.1016/S0169-409X(02)00228-410.1016/S0169-409X(02)00228-4 ↗
96. 10.1038/nnano.2007.38710.1038/nnano.2007.387 ↗
97. 10.1038/nnano.2007.38710.1038/nnano.2007.387 ↗
98. 10.1016/j.cej.2010.02.00310.1016/j.cej.2010.02.003 ↗
99. 10.2146/ajhp13012610.2146/ajhp130126 ↗
100. 10.1093/annonc/mdt17310.1093/annonc/mdt173 ↗